Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

COVID-19 vaccination is generally safe for people with Hidradenitis Suppurativa.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

A man developed a benign tumor at his COVID-19 vaccination site, which was successfully removed with surgery.

More symptoms during initial COVID infection increase the risk of long-term effects.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Many recovered COVID-19 patients in Saudi Arabia still experience symptoms like fatigue and anxiety, especially older adults and those with other health issues.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.

Beau's lines on nails may indicate severe COVID-19 or vaccination response.

Understanding SARS-CoV-2's spread and immune response is key to developing treatments and vaccines, but preventive measures remain important.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Digital games are part of new media but need a deeper look at their complex nature and cultural roots.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.